1. Optovue

    0 Comments Leave a Comment

    1-15 of 690 1 2 3 4 ... 44 45 46 »

    1. Mentioned In 690 Articles

    2. Methods and apparatus for retina blood vessel assessment with OCT angiography

      Explore uspto.gov Ophthalmology , Patents
      Methods and apparatus for retina blood vessel assessment with OCT angiography
      A method of processing a 3D OCT dataset is present. A method according to some embodiments of the present invention includes obtaining an OCT data from the 3D OCT dataset; obtaining an OCTA data from the 3D OCT dataset; performing segmentation for at least one boundary on the OCT data; processing the OCTA data in a region of interest to create at least one image representation by assigning a value ...
      Read Full Article
      Mentions: Optovue Jay Wei Richard B. Rosen

    3. Optical coherence tomography angiography of types 1 and 2 choroidal neovascularization in age-related macular degeneration during anti-VEGF therapy: evaluation of a new quantitative method

      Explore Nature Publishing Group Ophthalmology
      Optical coherence tomography angiography of types 1 and 2 choroidal neovascularization in age-related macular degeneration during anti-VEGF therapy: evaluation of a new quantitative method
      ...ative age-related macular degeneration (AMD) was diagnosed in 28 patients. OCT-angiography (OCT-A) (Avanti/FA Optovue) performed before and after anti-VEGF therapy. The OCT-A data sets were exported to an external image ...
      Read Full Article
      Mentions: Optovue

    4. Cluster analysis of computerized visual field and optical coherence tomography–ganglion cell complex defects in high intraocular pressure patients or early stage glaucoma

      Explore SAGE Journals Ophthalmology
      Cluster analysis of computerized visual field and optical coherence tomography–ganglion cell complex defects in high intraocular pressure patients or early stage glaucoma
      ...d 30 visual field (Octopus G1x Dynamic strategy) and optical coherence tomographyganglion cell complex (I-Vue Optovue) analyses were performed for each eye selected; 68 eyes were tested and retested from two to seven tim...
      Read Full Article
      Mentions: Optovue Sapienza University of Rome

    5. Iridocorneal angle assessment of companion rabbits using gonioscopy, spectral‐domain optical coherence tomography (Optovue iVue®), high‐resolution ultrasound, and Pentacam® HR imaging

      Explore Wiley Online Library Ophthalmology
      Iridocorneal angle assessment of companion rabbits using gonioscopy, spectral‐domain optical coherence tomography (Optovue iVue®), high‐resolution ultrasound, and Pentacam® HR imaging
      Objective Iridocorneal angle (ICA) narrowing is a known risk factor for primary glaucoma in multiple species, but has not been described in companion rabbits. This study aimed to develop an ICA grading scheme for companion rabbits to enable early glaucoma predisposition diagnosis. Animals studied Twenty healthy rabbits of varying breeds and ages. Procedures Rabbits received complete ophthalmic examinations, including gonioscopy, and imaging of the ICA using spectral‐domain optical coherence ...
      Read Full Article
      Mentions: Optovue

    6. Optical Coherence Tomography Angiography for Evaluation of Reperfusion following Pterygium Surgery

      Explore American Journal of Ophthalmology Ophthalmology
      Optical Coherence Tomography Angiography for Evaluation of Reperfusion following Pterygium Surgery
      Purpose To describe the use of optical coherence tomography angiography (OCTA) to quantitatively monitor the conjunctival graft revascularization after pterygium excision and conjunctival autograft (CAG) transplantation. Design Prospective, interventional case series. Methods Ten patients undergoing pterygium excision and femtosecond laser-assisted CAG transplantation were included. OCTA was performed at 1 week, 1 and 3 months postoperatively at the CAG transplantation site and harvested area. The vessel density at three different depths ...
      Read Full Article
      Mentions: Optovue Jodhbir S. Mehta

    7. Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer’s Disease on optical coherence tomography angiography

      Explore Journals | PLOS Neurology , Ophthalmology
      Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer’s Disease on optical coherence tomography angiography
      ...ndividual with (F) showing the cross-section segmentation of the SCP. We used the RTVue-XR OCT Avanti System (Optovue Inc, Fremont, California, USA. Software Version 2016.1.0.26) with split-spectrum amplitude-decorrelati...
      Read Full Article
      Mentions: National Institutes of Health Optovue Northwestern University

    11. Detection of Non-exudative Choroidal Neovascularization and Progression to Exudative Choroidal Neovascularization Using Optical Coherence Tomography Angiography

      Explore ScienceDirect Ophthalmology
      Detection of Non-exudative Choroidal Neovascularization and Progression to Exudative Choroidal Neovascularization Using Optical Coherence Tomography Angiography
      ...ative neovascular AMD in the fellow eye. Methods Study participants underwent spectral domain OCTA (AngioVue, Optovue, Inc), clinical exam, and structural OCT at baseline and six-month intervals for two years. OCTA image...
      Read Full Article
      Mentions: Optovue David Huang Oregon Health & Science University

    16. Precision of OCT and OCTA-based Ocular Measurements

      Explore Home - ClinicalTrials.gov Ophthalmology , Clinical Trials
      Precision of OCT and OCTA-based Ocular Measurements
      The purpose of this study is to assess precision of measurements of vascular structures and the anatomical structures of the posterior pole of the eye based on OCTA and OCT scans in normal subjects, glaucoma patients, and retina patients, and to assess measurements of corneal layers based on corneal OCT scans in normal subjects and cornea patients.
      Read Full Article
      Mentions: Optovue
    17. 1-15 of 690 1 2 3 4 ... 44 45 46 »
  1. Search:

  2. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology

    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents

    3. Technology:

      Broadband Sources, Probes, Tunable Sources

    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks

  4. About Optovue

    Optovue

    Optovue, Inc., a privately-held medical device company founded in 2003 and based in Fremont, Calif., is dedicated to the development and commercialization of high-speed optical coherence technology used to facilitate the diagnosis and management of eye diseases, many of which may lead to permanent blindness. For more information, visit www.optovue.com.

  5. Related Topics

    1. Optovue Receives FDA Clearance for Cornea/Anterior Module for RTVue
      394 articles also mentioned Optovue RTVue-100
    2. Carl Zeiss Meditec Sues, Seeks Protection of Proprietary Information
      191 articles also mentioned Carl Zeiss Meditec
    3. Optical Coherence Tomography Market To Top $800 Million By 2012
      94 articles also mentioned Topcon Medical Systems
    4. Spectral-domain optical coherence tomography represents step forward, physician says
      88 articles also mentioned Zeiss Cirrus HD-OCT
    5. Still evolving, OCT technology has revolutionized diagnostics
      88 articles also mentioned Heidelberg Engineering
    6. Optovue Announces Shipment of the 2000th RTVue Advanced OCT System and the 100th iVue Compact SD-OCT System
      69 articles also mentioned Optovue iVue

  6. Quotes about Optovue

    1. Our customers around the world provided a 19% revenue increase for 2009 over 2008...We have continuing strong support by representatives and distributor's world-wide, and all regions including the US are up significantly from 2008. The first fiscal quarter of 2010 demonstrated still another significant increase over 2009 numbers. The trend is clearly demonstrating that the clinical package offered by Optovue products is still highly desirable when faced with a number of product options.
      Gordon Wong in Optovue Announces 19% 2009 Revenue Increase Over 2008
    2. Gaining market share in the home country where Optovue manufactures is always satisfying...“Gaining market share in the home country where Optovue manufactures is always satisfying...The mission in 2012 is to continue our market growth world-wide utilizing our new TCP (Total Cornea Power) and V TRAC (Eye Tracking) options; as well as expand our iWellness programs.
      In Optovue Announces US sales orders for advanced OCT up 32% over previous year
    3. Haag-Streit is happy to partner with Optovue for its leadership in OCT technology and outstanding customer service. Our bundled technologies will create an advanced package that will provide a superior diagnostic tool to the ophthalmic industry.
      In Haag-Streit USA and Optovue Team Up to Introduce Octopus/Optovue Bundle